Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.

Autor: Gordon, S. C.1, Hamzeh, F. M.2, Pockros, P. J.3, Hoop, R. S.2, Buikema, A. R.4, Korner, E. J.2, Terrault, N. A.5
Zdroj: Alimentary Pharmacology & Therapeutics. Oct2013, Vol. 38 Issue 7, p784-793. 10p. 1 Diagram, 5 Charts, 1 Graph.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje